PMC:7755033 / 5764-6005
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 135 | 133-141 | Species | denotes | patients | Tax:9606 |
| 136 | 207-215 | Species | denotes | patients | Tax:9606 |
| 145 | 74-93 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 148 | 25-34 | Disease | denotes | pneumonia | MESH:D011014 |
| 149 | 115-123 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 150 | 124-132 | Disease | denotes | infected | MESH:D007239 |
| 151 | 203-206 | Disease | denotes | HIV | MESH:D015658 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T5 | 25-34 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T44 | 36-235 | Sentence | denotes | Combinations of protease inhibitor(s) lopinavir/ritonavir for the treatment of COVID-19 infected patients have been evaluated which have been used previously to treat HIV patients (Liu et al., 2020). |